+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study



Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study



Archives of Dermatological Research 278(3): 228-231



Chronic urticaria is a disease for which the available range of treatment modalities is limited. Ultraviolet radiation has recently been shown to affect histamine release from mast cells. We therefore studied the effects of PUVA and UVA on chronic urticaria. Nineteen patients took part in the study, which was designed as a randomized double-blind study. Eleven patients received PUVA, and 8 received UVA plus a placebo. In the PUVA group, 7 patients showed improvement, 3 noticed no change, and 1 became worse. In the group that received UVA plus placebo, 5 patients experienced an improvement, whereas the other 3 showed no change. The differences between the groups were not statistically significant. However, the probability of achieving this degree of improvement in both groups just by chance is less than 1%. Consequently, the improvement noted could have been due to either UVA alone or a placebo effect. It is concluded that PUVA is not better than UVA in the treatment of chronic urticaria.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041852081

Download citation: RISBibTeXText

PMID: 2425755

DOI: 10.1007/bf00412929


Related references

Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica 177(4): 218-224, 1988

A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis. British Journal of Dermatology 110(2): 215-220, 1984

A double-blind placebo controlled study of terfenadine in the treatment of chronic idiopathic urticaria. British Journal of Clinical Practice 41(8): 859-861, 1987

Treatment of chronic urticaria with Zafirluklast A double-blind, placebo-controlled cross-over study on 46 patients. Allergy 56(Supplement 68): 149-150, 2001

Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria a randomized double blind study. British Journal of Clinical Pharmacology 20(6): 639-642, 1985

Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. British Journal of Dermatology 154(3): 533-538, 2006

Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study. Allergy 62(5): 539-546, 2007

Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double-blind, placebo-controlled study. International Journal of Dermatology 26(10): 653-654, 1987

Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clinical and Experimental Allergy 34(9): 1401-1407, 2004

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clinical and Experimental Allergy 31(10): 1607-1614, 2001

Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Annals of Allergy, Asthma and Immunology 94(6): 662-669, 2005

Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. Drugs 52 Suppl 1: 30-34, 1996

Once-Daily Fexofenadine Treatment for Chronic Idiopathic Urticaria: A Multicenter, Randomized, Double-blind, Placebo-controlled Study. Yearbook of Dermatology and Dermatologic Surgery 2006: 48-49, 2006

A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria. Indian Journal of Dermatology, Venereology and Leprology 80(2): 122-128, 2014

Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. International Journal of Dermatology 45(4): 469-474, 2006